90739 studies found for:    United States
Show Display Options
Rank Status Study
1 Recruiting A Study Comparing ABT-494 to Placebo in Subjects With Rheumatoid Arthritis on a Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response to csDMARDs Alone
Condition: Rheumatoid Arthritis
Interventions: Drug: ABT-494;   Drug: Placebo
2 Not yet recruiting Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement
Condition: Osteoarthritis
Intervention: Drug: Investigational Medical Product (IMP) administered in parent study
3 Recruiting Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Adenocarcinoma;   Stage II Prostate Adenocarcinoma;   Stage III Prostate Adenocarcinoma
Interventions: Radiation: 3-Dimensional Conformal Radiation Therapy;   Radiation: Intensity-Modulated Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration;   Radiation: Selective External Radiation Therapy
4 Not yet recruiting BI655066 in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment
Condition: Psoriasis
Interventions: Drug: BI 655066;   Drug: Placebo
5 Recruiting Concurrent Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma
Conditions: Giant Cell Glioblastoma;   Glioblastoma;   Gliosarcoma;   Recurrent Brain Neoplasm
Interventions: Radiation: 3-Dimensional Conformal Radiation Therapy;   Biological: Bevacizumab;   Radiation: Intensity-Modulated Radiation Therapy;   Radiation: Proton Beam Radiation Therapy
6 Not yet recruiting A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy
Conditions: Vulvovaginal Atrophy;   Menopause;   Dyspareunia
Interventions: Drug: Estradiol Vaginal Capsule (EVC);   Drug: Placebo
7 Recruiting Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Conditions: Hyperlipidemia;   Dyslipidemia
Interventions: Drug: NK-104-CR;   Drug: Placebo;   Drug: Livalo
8 Recruiting CREAD Study" A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Interventions: Drug: Crenezumab;   Drug: Placebo
9 Recruiting Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk
Conditions: Hypercholesterolemia;   Atherosclerotic Cardiovascular Diseases
Interventions: Drug: ETC-1002;   Drug: Placebo
10 Not yet recruiting A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Condition: Prostate Cancer
Interventions: Drug: Degarelix;   Drug: Leuprolide
11 Not yet recruiting A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma
Condition: Soft Tissue Sarcoma
Interventions: Drug: Olaratumab;   Drug: Gemcitabine;   Drug: Docetaxel;   Drug: Placebo
12 Recruiting A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity
Conditions: Posttraumatic Stress Disorder;   Depression;   Alcohol-Related Disorders;   Suicidal Ideation;   Substance-Related Disorders;   Mild Cognitive Impairment;   Quality of Life;   Pain;   Wounds and Injury;   Brain Injuries;   Chronic Disease
Interventions: Behavioral: Motivational Interviewing;   Behavioral: Cognitive Behavioral Therapy Elements;   Behavioral: Care Management;   Drug: Fluoxetine;   Drug: Fluvoxamine;   Drug: Paroxetine;   Drug: Setraline;   Drug: Citalopram;   Drug: Venlafaxine;   Drug: Duloxetine;   Drug: Mirtazapine;   Drug: Diphenhydramine;   Drug: Trazodone;   Drug: Prazosin
13 Completed A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: Ingenol Mebutate (Picato®);   Drug: Generic Ingenol Mebutate;   Drug: Vehicle Foam
14 Recruiting A Study to Evaluate Safety and Efficacy of TTP273 for 12 Weeks in Subjects With Type 2 Diabetes
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: TTP273;   Drug: Placebo
15 Recruiting Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid Dependence
Condition: Opioid Use Disorders
Interventions: Drug: CAM2038 subcutaneous injection;   Drug: SL BPN tablets;   Drug: placebo subcutaneous (SC) injections;   Drug: SL placebo tablets
16 Recruiting An Open Label Study of CM-AT for the Treatment of Children With Autism
Condition: Autism
Intervention: Drug: CM-AT
17 Recruiting A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
Condition: Smoking
Interventions: Other: THS 2.2;   Other: CC
18 Completed Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
Condition: Asthma
Interventions: Drug: Fluticasone / Salmeterol;   Drug: Placebo;   Drug: Advair Diskus 100/50
19 Recruiting Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Interventions: Drug: semaglutide;   Drug: Dulaglutide
20 Recruiting 12-Week Study of DS-8500a in Subjects With Type 2 Diabetes Mellitus on Metformin
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin 100 mg;   Drug: DS-8500a 25mg;   Drug: placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years